简述摘要
Location: China, Guangdong Province, Shenzhen
Employees: 201-500
Investors 1
| Date | Name | Website |
| 11.02.2021 | Cathay Cap... | cathaycapi... |
Mentions in press and media 14
| Date | Title | Description |
| 23.12.2025 | Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy | DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a nove... |
| 18.12.2025 | VetMew, the AI-powered Pet Health Support App, Officially Launches in North American Market | BOSTON, Dec. 18, 2025 /PRNewswire/ -- VetMew, an AI-powered pet health support application, today announced its official launch in the North American market. The app delivers a groundbreaking tool designed to empower pet owners with immedia... |
| 10.11.2025 | Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo | BOSTON, Nov. 10, 2025 /PRNewswire/ -- Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostic... |
| 05.08.2025 | Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors | DONGGUAN, China, Aug 5, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient enrollment in China for its Phase I clinical tria... |
| 12.06.2025 | Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025 | BOSTON, June 12, 2025 /PRNewswire/ -- Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the BIO International Convention 2025 (BIO 2025), tak... |
| 28.02.2025 | Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors | DONGGUAN, China, Feb. 28, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the Investiga... |
| 15.10.2024 | Fapon showcases its total IVD solutions at Hospital Expo to empower local Indonesian IVD industry | DONGGUAN, China, Oct. 15, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is excited to participate in the Hospital Expo in Jakarta, Indonesia, from October 16 – 19. Fapon will showcase its total IVD solutions, including... |
| 18.08.2024 | Fapon Biotech Delivers Antigen Diagnostic Solutions to Help Control Monkeypox Outbreak in Africa | SHENZHEN, China, Aug. 18, 2024 /PRNewswire/ -- Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing innovative diagnostic solutions. As the World He... |
| 01.08.2024 | The Director General of Pharmaceuticals and Medical Devices Visits Fapon in Indonesia | JAKARTA, Indonesia, Aug. 1, 2024 /PRNewswire/ -- The Ministry of Health of the Republic of Indonesia, represented by the Director General of Pharmaceuticals and Medical Devices (Dirjen Falmakes), Dr. Dra. Lucia Rizka Andalucia, along with t... |
| 04.06.2024 | Fapon Biopharma Announces a Safer Immunotherapy for Cancers | SAN DIEGO, June 4, 2024 /PRNewswire/ -- At Bio International Convention 2024, which is taking place here in San Diego during June 3-6, Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, has announced an ... |
Show more